Clinical Trial Update: Psoriatic Arthritis Treat to Target vs. Usual Care [NA]

View source ↗

Summary

A clinical trial evaluating a treat-to-target approach versus usual care for psoriatic arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Snippet

Sponsor: Pope Research Corporation | Conditions: Psoriatic Arthritis (PsA) | NA | Status: WITHDRAWN